Skip to main content
HairCited

Local Injection versus Topical Microneedling of Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review.

Johannes Albert Biben, Ryan Reinhart, Karina Karina, Kuswan Ambar Pamungkas, Krista Ekaputri et al.
Other Archives of plastic surgery 2025
PubMed DOI CC-BY PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D40083615'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Тип исследования
systematic review
Вмешательство
Local Injection versus Topical Microneedling of Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review. Autologous platelet-rich plasma (PRP) via syringe injection or topical application with microneedlin
Препарат сравнения
Placebo
Направление эффекта
Positive
Риск систематической ошибки
Unclear

Abstract

Autologous platelet-rich plasma (PRP) has gained popularity for hair restoration due to its effectiveness and safety. PRP could be administered through direct local injections to the scalp or applied topically with the aid of microneedling therapy. This systematic review aims to elaborate on the effectiveness of PRP administered with syringe injection and topical PRP with microneedling combination for the treatment of androgenetic alopecia (AGA). A literature search was employed through PubMed, Cochrane Central Register of Controlled Trials, Embase, Web of Science, and Scopus. The database was searched using terms and keywords: "platelet-rich plasma" and "microneedling" and "androgenetic alopecia." Inclusion criteria are human study, patients with AGA, studies that compare PRP with syringe injection and the combination of PRP and microneedling. Exclusion criteria are animal study, review, case reports, or studies on other form of alopecia. A total of 108 articles found in the database. Title and abstract screening yield 12 articles. After full-text reading three articles were included in the review. A combination of PRP and microneedling appears to yield more superior results than direct syringe injection. Topical PRP and microneedling potentially give better results on AGA cases. Further high-quality studies with uniform protocol are needed to confirm these findings. Level of Evidence  I.

Full Text

PDF
Loading PDF...

Figures

Tables

Table 1

StudyItems Muhammad 12 Ramadan 13 Ozcan 14
Was the study described as randomized?+1+1+1
Was the method of randomization appropriate?+1−1+1
Was the study described as blinded?00, 50
Was the method of blinding appropriate?0+10
Was there a description of withdrawals and dropouts?000
Was there a clear description of the inclusion/exclusion criteria?+1+1+1
Was the method used to assess adverse effects described?0+10
Was the method of statistical analysis described?+1+1+1
Total score43, 54

Table 2

StudyTotal subjectsInterventionPRP protocolInjection and microneedling protocol Additional therapy a Treatment and follow-up protocol
Muhammad et al 12 (2022) n  = 60 Male = 57Female = 3Group I = 30Group II = 30Group Iconventional PRPGroup IIPRP + microneedlingVolume of blood: 20 mLAnticoagulant: citrate phosphate dextrose with adenineCentrifugation I: 1500 rpm, 15 minCentrifugation II: 4000 rpm, 10 minPlatelet activator: yes, with calcium gluconateDevice: dermaroller• Depth: 2 mm• Passes: no data• Injection• Syringe: 1 mL• Needle: no data• Space: no dataNo data3 sessions1-mo intervalFollow-up per 3 mo
Ramadan et al 13 (2020) n  = 126 Male = 46Female = 80Group I = 42Group II = 42Group III = 42Group Iconventional PRPGroup IIPRP + microneedlingGroup IIIcontrolVolume of blood: 10 mLAnticoagulant: citrateCentrifugation I: 547.82 G, 10 minPlatelet activator: noDevice: dermapen• Depth: 2 mm• Passes: 3 times• Injection• Syringe: no data• Needle: no data• Space: no dataFemale:topical minoxidil 5% qd, oral spironolactone 100 mg qdMale:topical minoxidil 5% bid, oral finasteride 2.5 mg qd3–6 sessions1-mo intervalFollow-up• Third month• Sixth month3 mo after last session
Ozcan et al 14 (2021) n  = 62 Male = 62 Female = 0Group I = 31Group II = 31Group Iconventional PRPGroup IIPRP + microneedlingVolume of blood: 10 mLAnticoagulant: citrateCentrifugation I: 2800 G, 8 minPlatelet activator: noDevice: dermapen• Depth: 1.5 mm• Passes: no data• Injection• Syringe: 5 mL• Needle: 30 G • Space: per cm 2 No additional therapy4 sessionsInterval• First three sessions: 2 wk• Last session 1 mo after the third session.Follow-up: no data

Table 3

StudyHair count/volume/density/diameterChange of anagen/telogen hairHair pull testPatient assessmentPhysician assessment
Muhammad et al 12 (2022) Hair count increase (mean ± SD)Group I: 17.88 ± 10.15%Group II: 24.53 ± 9.49%p  = 0.011 Hair pull test conversion (positive to negative)Group I: 51.9%Group II: 82.1%Conversion of hair loss perception from “severe” to “mild/moderate”Group I: 73.9%Group II: 88%
Ramadan et al 13 (2020) 1. Improvement of hair volume/density by clinical evaluation (mean ± SD)Group I: 64.3 ± 14.3Group II: 78.3 ± 10.6Group III: 35.7 ± 14.9p  < 0.001 (between groups) p  = 0.036 (group I vs. II) 2. Improvement of hair density by dermoscopy (mean ± SD)Group I: 16.7 ± 12.8Group II: 56.3 ± 25.2Group III: 10.8 ± 8.4p  < 0.001 (between groups) p  < 0.001 (group I vs. II) 3. Improvement of hair diameter by dermoscopy (mean ± SD)Group I: 20.3 ± 16.7Group II: 52.3 ± 34.0Group III: 13.5 ± 6.6p  < 0.001 (between groups) p  < 0.001 (group I vs. II) Negative in over 95% of all patientsSatisfaction rate: 88% of all patients
Ozcan et al 14 (2021) 1. Improvement of hair count (mean ± SD)Group I: 4.14 ± 8.04Group II: 4.60 ± 9.76p  = 0.838 2. Improvement of hair density (mean ± SD)Group I: 7.57 ± 14.71Group II: 8.39 ± 17.78p  = 0.833 1. Change of anagen hair (mean ± SD)Group I: −6 ± 16.06Group II: 6.52 ± 19.74p  = 0.016 2. Change of telogen hair (mean ± SD)Group I: 6 ± 16.06Group II: −6.65 ± 19.73p  = 0.014 1. Before vs. after in both group I and group IIp  < 0.001 2. After treatment: group I vs. group IIp  = 0.506 Group I vs. group IIp  > 0.05 Group I vs. group IIp  > 0.05

Table 4

Study Adverse effect a
Muhammad et al 12 (2022) The “severe” and “very severe” pain perception levelGroup I: 40%Grade II: 0%
Ramadan et al 13 (2020) Group I (23 patients): burning pain, scalp pain, headacheGroup II: noneGroup III: none
Ozcan et al 14 (2021) No data

References

  1. Advances in hair growth
  2. Nonsurgical hair restoration treatment Cutis, 2019
  3. Androgenetic alopecia: therapy update Drugs, 2023
  4. The inflammatory component of androgenetic alopecia J Am Acad Dermatol, 2022
  5. Novel drug delivery approaches for the management of hair loss Expert Opin Drug Deliv, 2020
  6. Physiopathology and current treatments of androgenetic alopecia: going beyond androgens and anti-androgens Dermatol Ther, 2019
  7. What's new in therapy for male androgenetic alopecia? Am J Clin Dermatol, 2023
  8. Platelet-rich plasma: evolving role in plastic surgery Plast Reconstr Surg, 2021
  9. Safety concerns when using novel medications to treat alopecia Expert Opin Drug Saf, 2018
  10. Platelet-rich plasma for hair restoration Facial Plast Surg Clin North Am, 2020
  11. Clinical administration of microneedles: skin puncture, pain and sensation Biomed Microdevices, 2009
  12. Comparison of efficacy of platelet-rich plasma (PRP) with PRP microneedling in androgenetic alopecia Cureus, 2022
  13. Evaluation of adding platelet-rich plasma to combined medical therapy in androgenetic alopecia J Cosmet Dermatol, 2021
  14. Platelet rich plasma application by dermapen microneedling and intradermal point-by-point injection methods, and their comparison with clinical findings and trichoscan in patients with androgenetic alopecia Dermatol Ther, 2022
  15. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement Syst Rev, 2015
  16. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ, 2021
  17. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care
  18. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996
  19. Protective effect of surgery against early subtalar arthrodesis in displaced intra-articular calcaneal fractures: a meta-analysis Medicine (Baltimore), 2015
  20. Micro-needling depth penetration, presence of pigment particles, and fluorescein-stained platelets: clinical usage for aesthetic concerns Aesthet Surg J, 2017
  21. Platelet-rich plasma with microneedling in androgenetic alopecia: study of efficacy of the treatment and the number of sessions required J Cutan Aesthet Surg, 2021
  22. Microneedling with platelet-rich plasma versus microneedling with topical 5% minoxidil in patients with androgenetic alopecia- a comparative study J Evol Med Dent Sci, 2017
  23. A comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia Int J Trichology, 2017
  24. Dermoscopic assessment of microneedling alone versus microneedling with platelet-rich plasma in cases of male pattern alopecia: a split-head comparative study Int J Trichology, 2020
  25. Efficacy of platelet-rich plasma and concentrated growth factor in treating androgenetic alopecia - a retrospective study Ann Maxillofac Surg, 2020
  26. Platelet-rich plasma and microneedling improves hair growth in patients of androgenetic alopecia when used as an adjuvant to minoxidil J Cosmet Dermatol, 2018
  27. Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation J Cosmet Dermatol, 2018
  28. A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia Expert Opin Biol Ther, 2020
  29. Use of activated platelet-rich plasma (A-PRP) on alopecia: a systematic review and meta-analysis Aesthet Surg J, 2023
  30. Platelet-rich plasma as a therapy for androgenic alopecia: a systematic review and meta-analysis J Dermatolog Treat, 2022
  31. Microneedling and its use in hair loss disorders: a systematic review Dermatol Ther (Heidelb), 2022
  32. The thickness of human scalp: normal and bald J Invest Dermatol, 1972

Used In Evidence Reviews

Similar Papers